Golden Biotechnology Corp (4132)

Golden Biotechnology Corp. (GBC,GoldenBiotech) (TPEx4132) is an advanced pharmaceutical development company focused on meeting the pressing demand for effective medications among patients with critical medical needs. With over a decade of experience and technical know-how in cancer drug research and manufacturing, GoldenBiotech stands as one of the few organizations that are capable of independently developing NCEs (New Chemical Entities) as novel drugs. We possess comprehensive expertise in the complete process of drug development. GBC conducted comprehensive preclinical trials in collaboration with several internationally renowned research institutions and initiated research and multi-national, multi-center clinical trials targeting indications such as cancer, cardiovascular...

New drug discovery,clinical trials,oncology,cancer treatment,nce,autoimmune,covid-19,neurodegenerative,cardio vascular,nsclc,pancreatic cancer,aml,alzheimer's disease,health supplements,and orphan drug designation

Golden biotechnology corp (4132) operates in the Pharmaceutical manufacturing industry.

Golden biotechnology corp (4132)'s revenue is 1m - 10m

Golden biotechnology corp (4132) has 11 - 50 employees.